[Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up]. [electronic resource]
Producer: 20070504Description: 2397-404 p. digitalISSN:- 0030-6002
- Activities of Daily Living
- Adult
- Aged
- Aged, 80 and over
- Antidepressive Agents, Second-Generation -- therapeutic use
- Depression -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Hungary -- epidemiology
- Male
- Middle Aged
- Paroxetine -- therapeutic use
- Prevalence
- Quality of Life
- Selective Serotonin Reuptake Inhibitors -- therapeutic use
- Stroke -- psychology
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase IV; English Abstract; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.